Ensign Peak Advisors’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
|
|||||
|
2025
Q3 | $13.6M | Hold |
|
|||||
|
2025
Q2 | $7.36M | Buy |
|
|||||
|
2025
Q1 | $6.3M | Buy |
|
|||||
|
2024
Q4 | $1.32M | Hold |
|
|||||
|
2024
Q3 | $1.26M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $1.41M | Hold |
|
|||||
|
2023
Q4 | $996K | Hold |
|
|||||
|
2023
Q3 | $810K | Hold |
|
|||||
|
2023
Q2 | $775K | Hold |
|
|||||
|
2023
Q1 | $482K | Sell |
|
|||||
|
2022
Q4 | $770K | Hold |
|
|||||
|
2022
Q3 | $998K | Buy |
|
|||||
|
2022
Q2 | $599K | Sell |
|
|||||
|
2022
Q1 | $2.84M | Sell |
|
|||||
|
2021
Q4 | $3.87M | Buy |
|
|||||
|
2021
Q3 | $4.78M | Sell |
|
|||||
|
2021
Q2 | $7.77M | Buy |
|